Innovation in Action
Real-world cases studies, outcomes, and success stories demonstrating how our technology is transforming cancer patient care.
Below are some of the patient case-studies:
Case Study 07
Patient Details
Male
33 years
Clinical Presentation
Sigmoid colon with peritoneal metastasis
Clinical History
FOLFOX x 4 # - very good partial response.
SX--HIPEC
FOLFOX X8 # +Bevacizumab maintenance
Patient was monitored with CTC test.
Test Result
1 CTC was found in CTC Cluster form indicating aggressive residual disease.
Recurrence in liver found by PET Scan.
Clinical Outcome
Patient succumbed to disease.
Case Study 08
Patient Details
Female
45 years
Clinical Presentation
Ca Breast TNBC
Clinical History
RT.MRM -pT= 4.5 cm,N0. BRCA +ve
4# AC-T x 4#-XRT to CW/SCF.
1 yr of capecitabine (low dose)
Patient was monitored with CTC test.
Test Result
Longitudinal monitoring by CTC test shows absence of CTCs.
Clinical Outcome
Patient on clinical follow up
Case Study 09
Patient Details
Female
68 years
Clinical Presentation
Ca Breastp
T2N2M0 ,ER+/PR+/HER2+(fish negative)
Clinical History
Acx 4- Taxanes x 12 –XRT to CW/SCF.
Patient monitored with CTC test.
Test Result
After initial treatment, 2 CTCs with 1 CTC Cluster was found.
Clinical Outcome
Treatment was changed to capecitabine + hormonal therapy.
Longitudinal monitoring by CTC test shows absence of CTCs.
Case Study 10
Patient Details
Male
55 years
Clinical Presentation
Ca Colon with solitary liver mets.
Clinical History
NACT- folfirinox x 4#
SX for colon and liver
Adj . FOLFOX X 8#.
Patient monitored with CTC test.
Test Result
Latest CTC test shows, 2 CTCs.
However, both PET and MRI are negative.
There is discordance between CTC and imaging techniques.
Clinical Outcome
Patient on follow up. CTC may be repeated in 3 months.
Case Study 11
Patient Details
Female
50 years
Clinical Presentation
Ca Ovary Stage IIIC
Clinical History
Primary cytoreduction
6# pacli- carbo
Test Result
2 CTCs were found indicating residual disease.
PET Scan confirmed local recurrence.
Clinical Outcome
Patient was put on Oral Metronomic Chemotherapy (OMCT)
Case Study 12
Patient Details
Female
50 years
Clinical Presentation
Ca Breast – RT MRM done
p/w sternal mets and ipsilateral SC LN mets
Clinical History
No chemo/RT/HT taken due to fear
Chemo- AC x 6# - XRT to sternal including Supraclav field
Hormonal therapy x 10 yrs
Test Result
0 CTC were found.
PET Scan confirmed normal
Clinical Outcome
Patient on normal follow up.
- Page 2
Early detection is half the battle won.
Book a Test
Simply book a Test online or over a phone call and schedule a visit by our registered phlebotomists.
Sample Collection
Upon booking the Test, one of our registered phlebotomists shall visit and collect 10 ml of patient’s blood sample.
Receive Report
A set of diagnostics will be run on the patient’s blood sample and the report shall be provided in 7 working days upon receipt of sample on site.